On the other hand, adiponectin reduction in obesity contributes to increased cardiovascular risk as its protective roles in atherogenesis oppose that of leptin (Okamoto et al., 2002; Yamauchi et al., 2002). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.